ArticleThe Journal of infectious diseases2025
The Impact of Coronavirus Disease 2019 Nonpharmaceutical Interventions on Incidence of Acute Gastroenteritis and Acute Respiratory Infections Among US Military and Dependents.
Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Nonpharmaceutical interventions (NPIs) for coronavirus disease 2019 resulted in the reduction of many viral diseases aside from severe acute respiratory syndrome coronavirus 2, but their impact on the United States military or beneficiary population has not been assessed. Using TRICARE data (2016-2023), we modeled changes in acute gastroenteritis (AGE) and acute respiratory infection (ARI) encounters pre- and postpandemic. In 2020, AGE and ARI encounters decreased substantially (rate ratio [RR] = 0.50 [95% confidence interval {CI}, .31-.80]; RR = 0.60 [95% CI, .41-.88], respectively). By 2022, AGE remained suppressed while ARI had rebounded. Since 2022, AGE encounters among military personnel remained reduced compared to beneficiaries. NPIs had a greater, lasting effect on AGE than ARI encounters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.